Cargando…
Latent viruses can cause disease by disrupting the competition for the limiting factor p300/CBP
CBP and p300 are histone acetyltransferase coactivators that control the transcription of numerous genes in humans, viruses, and other organisms. Although two separate genes encode CBP and p300, they share a 61% sequence identity, and they are often mentioned together as p300/CBP. Zhou et al. showed...
Autores principales: | Polansky, Hanan, Schwab, Hava |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6260892/ https://www.ncbi.nlm.nih.gov/pubmed/30505323 http://dx.doi.org/10.1186/s11658-018-0121-1 |
Ejemplares similares
-
How a disruption of the competition between HIF-1 and p53 for limiting p300/CBP by latent viruses can cause disease
por: Polansky, Hanan, et al.
Publicado: (2018) -
Copy number of latent viruses, oncogenicity, and the microcompetition model
por: Polansky, Hanan, et al.
Publicado: (2018) -
Histone acetyltransferases CBP/p300 in tumorigenesis and CBP/p300 inhibitors as promising novel anticancer agents
por: Chen, Qingjuan, et al.
Publicado: (2022) -
Protein Lysine Acetylation
by p300/CBP
por: Dancy, Beverley M., et al.
Publicado: (2015) -
Loss of p300 and CBP disrupts histone acetylation at the mouse Sry promoter and causes XY gonadal sex reversal
por: Carré, Gwenn-Aël, et al.
Publicado: (2018)